Has Mark Falvo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,419 in general payments to Mark Falvo, MD across 61 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Falvo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Falvo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Falvo, MD

Colon & Rectal Surgery · Williamsville, NYNPI 1699966242

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,429 and has fallen 84.3% since, to $224 in 2025.

$5,419in general payments, 2019–2025

Across 61 payments — averaging $88.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$806
Medtronic$756
Integra Lifesciences Corporation$626
Johnson & Johnson$466
Fujifilm Healthcare Americas Corporation$371
Axonics, Inc.$288
plus $2K from 16 others

What the payments were for

Travel & lodging$2324%
Food & beverage$5,18696%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	7	$806
Medtronic	7	$756
Integra Lifesciences Corporation	6	$626
Johnson & Johnson	4	$466
Fujifilm Healthcare Americas Corporation	4	$371
Axonics, Inc.	4	$288
THD America, Inc.	2	$243
Activ Surgical, Inc.	2	$197
Coloplast	3	$190
Pentax Of America, Inc.	3	$189
Exact Sciences	2	$188
TELA Bio, Inc.	2	$173
Conmed Corporation	2	$161
Boston Scientific	2	$149
Innovation Technologies Inc	1	$143
Smith+Nephew	2	$142
KCI USA, Inc.	1	$118
Sanara Medtech Inc.	1	$105
Merck	2	$30
Hollister Incorporated	1	$30
Abbott	2	$28
Covidien LP	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTEGRA$1,244
Da Vinci Surgical System$625
INTEGRA DERMAL REGENERATION TEMPLATE$540
PRIMATRIX$540
FUJIFILM$355
ProGrip$297
Enseal X1$240
Axonics r-SNM System$238
Echelon Circular$236
VISTASEAL$226
Echelon Flex$226
OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$151
Irrisept$143
INSPIRA$138
RESOLUTION CLIP$137
ENDO GIA ULTRA$127
ActivSight$126
AMNIOEXCEL$125
TCC-EZ$125
OMNIGRAFT$125

How this compares

$5,419 in reported general payments places this provider in the 70th percentile of 177 colon & rectal surgery providers in New York.

See all colon & rectal surgery providers in New York →

Medicare billing

Part B allowed, 2024

$36,358

Medicare patients

111

Services billed

211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	12	$26

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Williamsville

Joseph MillsWilliamsville$9K
Steven BaroneWilliamsville$6K
Bashir AttuwaybiWilliamsville$6K
Timothy AdamsWilliamsville$4K
David RivadeneiraWoodbury$271K
Jerald WishnerMount Kisco$246K
Sanghyun KimNew York$154K
Ziad KronfolWest Nyack$81K
Lynn OconnorHuntington$63K
Mehraneh JafariNew York$50K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →